> Investors > 2017 News Releases

2017 News Releases

Keyword Search
 
Category
Year   
DateTitle 
05/04/17ACETO Reports Fiscal 2017 Third Quarter Results
Management to Host Conference Call on May 5, 2017 at 9:00 a.m. ET PORT WASHINGTON, N.Y., May 04, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the third quarter of fiscal 2017 ended March 31, 2017. Third Quarter Fiscal 2017 versus Third Quarter Fiscal 2016 Net sales of $19... 
Printer Friendly Version
05/04/17ACETO Board of Directors Declares Quarterly Cash Dividend 
PORT WASHINGTON, N.Y., May 04, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.065 per common share.  This quarterly cash dividend will be distributed on June 23, 2017 to shareholders of record as of June 9, 2017. ABOUT ACETO ... 
Printer Friendly Version
04/21/17ACETO Corporation Schedules Third Quarter Fiscal 2017 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y., April 21, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the third quarter of fiscal 2017 ended March 31, 2017 after the stock market close on Thursday, May 4, 2017. Management will host a conference call to discuss the operating and financial... 
Printer Friendly Version
03/31/17ACETO Subsidiary, Rising Pharmaceuticals, Launches Zileuton Extended Release Tablets, 600 mg
PORT WASHINGTON, N.Y., March 31, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, its finished dosage form generics subsidiary, has launched Zileuton Extended Release Tablets, 600 mg.  Rising holds the Abbreviated New Drug Application (ANDA) for this drug, an AB-rated generic v... 
Printer Friendly Version
03/28/17ACETO Subsidiary, Rising Pharmaceuticals, Launches Capecitabine Tablets, 150 & 500 mg
PORT WASHINGTON, N.Y., March 28, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, its finished dosage form generics subsidiary, has launched Capecitabine Tablets, 150 & 500 mg, an AB-rated generic version of Xeloda® Tablets from Hoffman La Roche.  Capecitabine Tablets, 150 ... 
Printer Friendly Version
02/15/17ACETO to Present at the 2017 RBC Capital Markets Global Healthcare Conference
PORT WASHINGTON, N.Y., Feb. 15, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Sal Guccione, President and CEO, will present at the 2017 RBC Capital Markets Global Healthcare Conference in New York on Wednesday, February 22, 2017 at 11:00AM ET. A webcast of the presentation will be available unde... 
Printer Friendly Version
02/02/17ACETO Reports Fiscal 2017 Second Quarter Results
Management to Host Conference Call on February 3, 2017 at 9:00 a.m. ET PORT WASHINGTON, N.Y., Feb. 02, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the second quarter of Fiscal 2017 ended December 31, 2016. Second Quarter Fiscal 2017 versus Second Quarter Fiscal 2016 Net ... 
Printer Friendly Version
02/02/17ACETO Appoints Vimal Kavuru to the Board of Directors
PORT WASHINGTON, N.Y., Feb. 02, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced that it has appointed Vimal Kavuru, 48 years old, to its Board of Directors, effective February 2, 2017. Chairman of the Board, Albert Eilender, commented, “We are pleased to welcome Vimal Kavuru to the ACETO Board of Directors. ... 
Printer Friendly Version
02/02/17ACETO Board of Directors Declares Quarterly Cash Dividend  
PORT WASHINGTON, N.Y., Feb. 02, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.065 per common share.  This quarterly cash dividend will be distributed on March 24, 2017 to shareholders of record as of March 10, 2017. ABOUT ACE... 
Printer Friendly Version
01/24/17ACETO Corporation Schedules Second Quarter Fiscal 2017 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y., Jan. 24, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the second quarter of fiscal 2017 ended December 31, 2016 after the stock market close on Thursday, February 2, 2017. Management will host a conference call to discuss the operating and f... 
Printer Friendly Version

top